<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms]]></title><description><![CDATA[<p>A Japanese pharma company has developed a drug that treats the root cause of a leading form of narcolepsy, and is celebrating as it becomes the first of its kind to receive American FDA approval. Narcolepsy type-1 afflicts 120,000 people in the US, and is characterized by sudden bouts of intense daytime drowsiness, disrupted nighttime […]</p>
<p>The post <a href="https://www.goodnewsnetwork.org/us-approves-first-drug-that-targets-root-cause-of-narcolepsy-rather-than-its-symptoms/">US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms</a> appeared first on <a href="https://www.goodnewsnetwork.org">Good News Network</a>.</p>]]></description><link>https://postcall.pub/topic/700f968e-3f31-4d90-adcc-e5d7d1564c7b/us-approves-first-drug-that-targets-root-cause-of-narcolepsy-rather-than-its-symptoms</link><generator>RSS for Node</generator><lastBuildDate>Sun, 30 Aug 2026 11:13:47 GMT</lastBuildDate><atom:link href="https://postcall.pub/topic/700f968e-3f31-4d90-adcc-e5d7d1564c7b.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 25 Aug 2026 15:00:15 GMT</pubDate><ttl>60</ttl></channel></rss>